Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 13.60
-0.15 (-1.09%)
At close: Jan 9, 2026
Cegedim Market Cap
Cegedim has a market cap or net worth of €187.25 million as of January 9, 2026. Its market cap has increased by 7.11% in one year.
Market Cap
187.25M
Enterprise Value
475.63M
Revenue
658.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
€13.60
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 187.25M, an increase of 64.47%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 187.25M | 0.37% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |